Intrapleural Dornase and Tissue Plasminogen Activator in pediatric empyema (DTPA): a study protocol for a randomized controlled trial

Intrapleural Dornase and Tissue Plasminogen Activator in pediatric empyema (DTPA): a study protocol for a randomized controlled trial

Abstract Background A randomized controlled trial of adults with empyema recently demonstrated decreased length of stay in hospital in patients treated with intrapleurally administered dornase alfa and fibrinolytics compared to fibrinolytics alone. Whether this treatment strategy is safe and effecti...

Full description

Bibliographic Details
Main Authors: Michael H. Livingston, Sanjay Mahant, Felix Ratjen, Bairbre L. Connolly, Kevin Thorpe, Muhammad Mamdani, Ian Maclusky, Sophie Laberge, Lucy Giglia, J. Mark Walton, Connie L. Yang, Ashley Roberts, Anna C. Shawyer, Mary Brindle, Simon J. Parsons, Cristina A. Stoian, Eyal Cohen
Format: Article
Language:English
Published: BMC 2017-06-01
Series:Trials
Subjects:
Empyema
Children
Chest tubes
Fibrinolytic agents
Randomized controlled trial
Online Access:http://link.springer.com/article/10.1186/s13063-017-2026-0

Internet

http://link.springer.com/article/10.1186/s13063-017-2026-0

Similar Items